A possible molecular mechanism of action of this SNP is that mutations in the promoter sequence in the ABCA1 gene cause changes in the affinity of Pol II for the promoter site, generating a decrease in mRNA, which could increase the risk of developing CAD. Here, ABCA1 is linked to coronary artery disorder.